{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:49:32Z","timestamp":1778881772332,"version":"3.51.4"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.1001\/jamaophthalmol.2023.3076","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:03:56Z","timestamp":1689260636000},"page":"766","source":"Crossref","is-referenced-by-count":9,"title":["Atropine, 0.01%, for Myopia Control"],"prefix":"10.1001","volume":"141","author":[{"given":"Jeffrey J.","family":"Walline","sequence":"first","affiliation":[{"name":"The Ohio State University College of Optometry, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Berntsen","sequence":"additional","affiliation":[{"name":"University of Houston College of Optometry, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"3","key":"eic230036r1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"eic230036r2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India: multicentric randomized trial.","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"issue":"11","key":"eic230036r3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial.","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"eic230036r4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control.","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"eic230036r6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ceo.v50.9","article-title":"Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: a randomised clinical trial.","volume":"50","author":"Lee","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"eic230036r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.2855","article-title":"Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial.","author":"Repka","journal-title":"JAMA Ophthalmol"},{"key":"eic230036r5","volume-title":"Myopia Outcome Study of Atropine in Children (Mosaic): Two-Year Results of Daily 0.01% Atropine in a European Population","author":"Flitcroft","year":"2023"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2807123\/jamaophthalmology_walline_2023_ic_230036_1691537660.20321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:15:58Z","timestamp":1692285358000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2807123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.3076","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}